Crossmark

Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic Modeling

Published Online: 2025-06-13

Authors

Bucher, Ronald W.

Graves, Lee M.

Bartlett, Derek W. https://orcid.org/0000-0001-8099-9069
License Information

Text and Data Mining valid from 2025-06-13

Version of Record valid from 2025-06-13
More Information

Article History

Received: 13 March 2025

Accepted: 14 May 2025

First Online: 13 June 2025

Declarations

:

: LMG is a scientific advisor to Madera Therapeutics. RWB and DWB declare no conflicts of interest for the work presented in this manuscript.

Document is current